Considering that the mechanism of action of these therapies is based on estrogen and progesterone receptors, there is a possibility that the expression of the receptors of these hormones is altered in endometriosis, which leads to the absence of a therapeutic response [15]. This evidence concerns the gene PGR and endometriosis.